Published on 3 Mar 2024 on Simply Wall St. via Yahoo Finance
DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Shareholders in DermTech, Inc. (NASDAQ:DMTK) had a terrible week, as shares crashed 31% to US$0.87 in the week since its latest yearly results. The results overall were pretty much dead in line with analyst forecasts; revenues were US$15m and statutory losses were US$3.09 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
See our latest analysis for DermTech
